EU5 Neurostimulation Devices Market Outlook to 2023

  • ID: 4331214
  • Report
  • 233 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Boston Scientific Corp
  • LivaNova PLC
  • Medtronic Plc
  • St. Jude Medical LLC
  • MORE
EU5 Neurostimulation Devices Market Outlook to 2023

Summary

The author’s new report, "EU5 Neurostimulation Devices Market Outlook to 2023", provides key market data on the EU5 Neurostimulation Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Cortical Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Neurostimulation Devices market segments - Cortical Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the EU5 Neurostimulation Devices market.
  • Key players covered include Medtronic plc, Boston Scientific Corp, St. Jude Medical LLC and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Boston Scientific Corp
  • LivaNova PLC
  • Medtronic Plc
  • St. Jude Medical LLC
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Neurostimulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neurostimulation Devices Market, EU5
3.1 Neurostimulation Devices Market, EU5, Revenue ($m), 2009-2023
3.2 Neurostimulation Devices Market, EU5, Category Comparison by Revenue ($m), 2009-2023
3.3 Neurostimulation Devices Market, EU5, Revenue ($m), 2009-2016
3.4 Neurostimulation Devices Market, EU5, Revenue ($m), 2016-2023
3.5 Neurostimulation Devices Market, EU5, Volume (Units), 2009-2023
3.6 Neurostimulation Devices Market, EU5, Volume (Units), 2009-2016
3.7 Neurostimulation Devices Market, EU5, Volume (Units), 2016-2023
3.8 Neurostimulation Devices Market, EU5, Company Share by Revenue ($m), 2016
4 Neurostimulation Devices Market, France
4.1 Neurostimulation Devices Market, France, Revenue ($m), 2009-2016
4.2 Neurostimulation Devices Market, France, Revenue ($m), 2016-2023
4.3 Neurostimulation Devices Market, France, Volume (Units), 2009-2016
4.4 Neurostimulation Devices Market, France, Volume (Units), 2016-2023
4.5 Neurostimulation Devices Market, France, Average Price ($), 2009-2023
4.6 Neurostimulation Devices Market, France, Distribution Share by Revenue ($m), 2015-2016
4.7 Neurostimulation Devices Market, France, Company Share by Revenue ($m), 2016
5 Neurostimulation Devices Market, Germany
5.1 Neurostimulation Devices Market, Germany, Revenue ($m), 2009-2016
5.2 Neurostimulation Devices Market, Germany, Revenue ($m), 2016-2023
5.3 Neurostimulation Devices Market, Germany, Volume (Units), 2009-2016
5.4 Neurostimulation Devices Market, Germany, Volume (Units), 2016-2023
5.5 Neurostimulation Devices Market, Germany, Average Price ($), 2009-2023
5.6 Neurostimulation Devices Market, Germany, Distribution Share by Revenue ($m), 2015-2016
5.7 Neurostimulation Devices Market, Germany, Company Share by Revenue ($m), 2016
6 Neurostimulation Devices Market, Italy
6.1 Neurostimulation Devices Market, Italy, Revenue ($m), 2009-2016
6.2 Neurostimulation Devices Market, Italy, Revenue ($m), 2016-2023
6.3 Neurostimulation Devices Market, Italy, Volume (Units), 2009-2016
6.4 Neurostimulation Devices Market, Italy, Volume (Units), 2016-2023
6.5 Neurostimulation Devices Market, Italy, Average Price ($), 2009-2023
6.6 Neurostimulation Devices Market, Italy, Distribution Share by Revenue ($m), 2015-2016
6.7 Neurostimulation Devices Market, Italy, Company Share by Revenue ($m), 2016
7 Neurostimulation Devices Market, Spain
7.1 Neurostimulation Devices Market, Spain, Revenue ($m), 2009-2016
7.2 Neurostimulation Devices Market, Spain, Revenue ($m), 2016-2023
7.3 Neurostimulation Devices Market, Spain, Volume (Units), 2009-2016
7.4 Neurostimulation Devices Market, Spain, Volume (Units), 2016-2023
7.5 Neurostimulation Devices Market, Spain, Average Price ($), 2009-2023
7.6 Neurostimulation Devices Market, Spain, Distribution Share by Revenue ($m), 2015-2016
7.7 Neurostimulation Devices Market, Spain, Company Share by Revenue ($m), 2016
8 Neurostimulation Devices Market, United Kingdom
8.1 Neurostimulation Devices Market, United Kingdom, Revenue ($m), 2009-2016
8.2 Neurostimulation Devices Market, United Kingdom, Revenue ($m), 2016-2023
8.3 Neurostimulation Devices Market, United Kingdom, Volume (Units), 2009-2016
8.4 Neurostimulation Devices Market, United Kingdom, Volume (Units), 2016-2023
8.5 Neurostimulation Devices Market, United Kingdom, Average Price ($), 2009-2023
8.6 Neurostimulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016
8.7 Neurostimulation Devices Market, United Kingdom, Company Share by Revenue ($m), 2016
9 Overview of Key Companies in EU5 Neurostimulation Devices Market
9.1 Medtronic Plc
9.1.1 Company Overview
9.2 St. Jude Medical LLC
9.2.1 Company Overview
9.3 Boston Scientific Corp
9.3.1 Company Overview
9.4 LivaNova PLC
9.4.1 Company Overview
9.5 Integra LifeSciences Holdings Corp
9.5.1 Company Overview
10 Neurostimulation Devices Market Pipeline Products
11 Recent Developments
11.1 Corporate Communications
11.1.1 May 16, 2017: LivaNova Announces Thad Huston as Chief Financial Officer
11.1.2 May 08, 2017: ZEISS Appoints New Fellow
11.1.3 Apr 24, 2017: Nexstim Appoints Hanna Kotola as VP of Legal Affairs
11.1.4 Apr 13, 2017: CorTec Presents New Structure of Advisory Board
11.1.5 Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia
11.1.6 Apr 11, 2017: Sanofi Announces Pre-quarterly Results Communication
11.1.7 Apr 10, 2017: Allergan Receives 2017 ENERGY STAR Partner of the Year - Sustained Excellence Award from U.S. Environmental Protection Agency
11.1.8 Apr 06, 2017: Allergan Names Daphne Karydas as Senior Vice President of Global Investor Relations & Strategy
11.1.9 Apr 05, 2017: Sanofi Appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee
11.1.10 Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation
11.1.11 Mar 28, 2017: Nexstim: The decisions of the Board of Directors
11.1.12 Mar 09, 2017: Changes in Nexstim Management Team
11.1.13 Mar 02, 2017: Sanofi’s Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charles as New Independent Directors
11.1.14 Feb 27, 2017: Lisa DeFrancesco, Vice President of Investor Relations, to Leave Allergan
11.1.15 Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK
11.1.16 Jan 30, 2017: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs
11.1.17 Jan 19, 2017: Abbas Hussain to leave GSK
11.1.18 Jan 19, 2017: Luke Miels appointed President, Global Pharmaceuticals, GSK
11.1.19 Dec 19, 2016: GSK announces Board changes
11.1.20 Nov 14, 2016: Adriane M. Brown to Join Allergan Board of Directors
11.1.21 Nov 02, 2016: LivaNova Announces CEO Transition: Damien McDonald to Succeed Andre-Michel Ballester
11.1.22 Oct 26, 2016: Allergan Announces Changes to Board Leadership
11.1.23 Oct 14, 2016: AorTech International Announces Board Changes
11.1.24 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer
11.1.25 Sep 30, 2016: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare
11.1.26 Sep 29, 2016: GlaxoSmithKline appoints Brian McNamara as CEO of GSK Consumer Healthcare
11.1.27 Sep 20, 2016: Emma Walmsley to succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline
11.1.28 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
11.1.29 Sep 07, 2016: Sanofi Appoints New Research Head for Immunology and Inflammation
11.1.30 Sep 06, 2016: Sanofi Board Of Directors Provides Update
11.1.31 Aug 01, 2016: LivaNova Names Chief Operating Officer
11.1.32 Jul 28, 2016: LivaNova Names Andrea L. Saia to its Board of Directors
11.1.33 Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization
11.1.34 Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board
11.1.35 Jul 07, 2016: GSK and Save the Children call for developing country innovations to enter $1 million award
11.1.36 Jun 14, 2016: GlaxoSmithKline: Executive Director Change
11.2 Financial Announcements
11.2.1 Jun 02, 2017: Nexstim Agrees on Extension of Tekes R&D Loan Repayments
11.2.2 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
11.2.3 May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17
11.2.4 May 09, 2017: Allergan Reports Solid Start to 2017 with 5% Increase in First Quarter GAAP Net Revenues to $3.6 Billion
11.2.5 May 03, 2017: LivaNova Reports First Quarter 2017 Results
11.2.6 Apr 28, 2017: Sanofi Delivers Robust Q1 2017 Financial Results
11.2.7 Apr 26, 2017: GSK delivers another quarter of continued progress
11.2.8 Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million
11.2.9 Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance
11.2.10 Mar 01, 2017: LivaNova Reports Fourth Quarter and Full-Year 2016 Results
11.2.11 Feb 28, 2017: Nexstim: Financial Statement Release 2016
11.2.12 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
11.2.13 Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17
11.2.14 Feb 08, 2017: Allergan Reports Strong 2016 Finish with 7% Increase in GAAP Net Revenues to $3.9 Billion in Fourth Quarter 2016
11.2.15 Feb 08, 2017: Sanofi Delivers 2016 Sales and Business EPS Growth at CER
11.2.16 Feb 08, 2017: GlaxoSmithKline: Results announcement for the fourth quarter 2016
11.2.17 Dec 21, 2016: AorTech International: Unaudited Interim Results For the six months ended 30 September 2016
11.2.18 Dec 09, 2016: Carl Zeiss Meditec continues its growth trend
11.2.19 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
11.2.20 Nov 02, 2016: LivaNova Reports Third Quarter 2016 Results
11.2.21 Nov 02, 2016: Allergan Reports Third Quarter 2016 Continuing Operations Performance with GAAP Net Revenues of $3.6 Billion; Announces Accelerated Share Repurchase, Initiation of Cash Dividend
11.2.22 Oct 28, 2016: Sanofi Announces Strong Q3 2016 Results
11.2.23 Oct 26, 2016: GlaxoSmithKline: Results Announcement for the third quarter 2016
11.2.24 Sep 29, 2016: LivaNova Announces Half-Year Financial Report
11.2.25 Sep 22, 2016: Mainstay Medical Announces Half Year Financial Results
11.2.26 Aug 25, 2016: Medtronic Reports First Quarter Financial Results
11.2.27 Aug 15, 2016: AorTech International: Audited results for the year ended 31 March 2016
11.2.28 Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery
11.2.29 Aug 08, 2016: Allergan Reports Strong Second Quarter 2016 Continuing Operations Performance with Net Revenues of $3.7 Billion
11.2.30 Aug 03, 2016: LivaNova Reports Second Quarter 2016 Results
11.2.31 Jul 29, 2016: Sanofi Announces Q2 2016 Results
11.2.32 Jul 29, 2016: Royalty report for Q2 2016 and update on lixisenatide (Lyxumia/Adlyxin) and iGlarLixi
11.2.33 Jul 27, 2016: GlaxoSmithKline: Results announcement for the second quarter 2016 and half-yearly financial report for the half-year 2016
11.3 Government and Public Interest
11.3.1 Jun 13, 2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivation’s Board
11.4 Legal And Regulatory
11.4.1 May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec
11.4.2 Feb 23, 2017: LivaNova Announces Its Intent to Delist from London Stock Exchange
11.4.3 Dec 21, 2016: AorTech Shares Dive As Losses And Lawsuit Against Former CEO Continue
11.4.4 Aug 17, 2016: ResMed Takes Fisher & Paykel to Court over Patents
11.4.5 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
11.5 Other Significant Developments
11.5.1 Apr 24, 2017: Aarhus University Hospital in Denmark Purchases NBS System from Nexstim
11.5.2 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
11.5.3 Dec 22, 2016: Nexstim pre-close business update
11.5.4 Dec 13, 2016: Magstim announces new distribution partnership in Netherlands
11.5.5 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
11.5.6 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
11.5.7 Oct 05, 2016: New Study Showcases Economic Impact of Allergan's Operations on New Jersey Economy
11.5.8 Jul 27, 2016: GSK announces significant new investment in UK manufacturing network
11.5.9 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day
11.6 Product News
11.6.1 Jan 05, 2017: Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference and Provides Preliminary Comments on 2017 Outlook
11.7 Strategy And Business Planning
11.7.1 Feb 16, 2017: GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms
11.7.2 Aug 09, 2016: EDA Board Acts to Encourage Global Pharmaceutical Company Allergan to Expand in New Jersey
11.7.3 Jul 06, 2016: LivaNova Sets Operating Model and Supporting Organization
11.7.4 Jul 05, 2016: Sanofi Enters Into Confidentiality Agreement With Medivation And Will Be Provided Due Diligence Access And Confidential Information
12 Appendix
12.1 Research Methodology
12.1.1 Coverage
12.1.2 Secondary Research
12.1.3 Primary Research
12.1.4 Company Share Analysis
12.1.5 Distribution Share Analysis
12.1.6 Benchmarking
12.2 Consulting
12.3 Contact
12.4 Disclaimer

List of Tables
Table 1: Neurostimulation Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2009-2023
Table 2: Neurostimulation Devices Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2009-2023
Table 3: Neurostimulation Devices Market, EU5, Revenue ($m), Historic, USD Constant, 2009-2016
Table 4: Neurostimulation Devices Market, EU5, Revenue ($m), Forecast, USD Constant, 2016-2023
Table 5: Neurostimulation Devices Market, EU5, Volume (Units), 2009-2023
Table 6: Neurostimulation Devices Market, EU5, Volume (Units), Historic, 2009-2016
Table 7: Neurostimulation Devices Market, EU5, Volume (Units), Forecast, 2016-2023
Table 8: Neurostimulation Devices Market, EU5, Company Share by Revenue ($m), USD Constant, 2016
Table 9: Neurostimulation Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Table 10: Neurostimulation Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 11: Neurostimulation Devices Market, France, Volume (Units), Historic, 2009-2016
Table 12: Neurostimulation Devices Market, France, Volume (Units), Forecast, 2016-2023
Table 13: Neurostimulation Devices Market, France, Average Price ($), Historic, 2009-2016
Table 14: Neurostimulation Devices Market, France, Average Price ($), Forecast, 2016-2023
Table 15: Neurostimulation Devices Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 16: Neurostimulation Devices Market, France, Company Share by Revenue ($m), USD Constant, 2016
Table 17: Neurostimulation Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Table 18: Neurostimulation Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 19: Neurostimulation Devices Market, Germany, Volume (Units), Historic, 2009-2016
Table 20: Neurostimulation Devices Market, Germany, Volume (Units), Forecast, 2016-2023
Table 21: Neurostimulation Devices Market, Germany, Average Price ($), Historic, 2009-2016
Table 22: Neurostimulation Devices Market, Germany, Average Price ($), Forecast, 2016-2023
Table 23: Neurostimulation Devices Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 24: Neurostimulation Devices Market, Germany, Company Share by Revenue ($m), USD Constant, 2016
Table 25: Neurostimulation Devices Market, Italy, Revenue ($m), USD Constant, Historic, 2009-2016
Table 26: Neurostimulation Devices Market, Italy, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 27: Neurostimulation Devices Market, Italy, Volume (Units), Historic, 2009-2016
Table 28: Neurostimulation Devices Market, Italy, Volume (Units), Forecast, 2016-2023
Table 29: Neurostimulation Devices Market, Italy, Average Price ($), Historic, 2009-2016
Table 30: Neurostimulation Devices Market, Italy, Average Price ($), Forecast, 2016-2023
Table 31: Neurostimulation Devices Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 32: Neurostimulation Devices Market, Italy, Company Share by Revenue ($m), USD Constant, 2016
Table 33: Neurostimulation Devices Market, Spain, Revenue ($m), USD Constant, Historic, 2009-2016
Table 34: Neurostimulation Devices Market, Spain, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 35: Neurostimulation Devices Market, Spain, Volume (Units), Historic, 2009-2016
Table 36: Neurostimulation Devices Market, Spain, Volume (Units), Forecast, 2016-2023
Table 37: Neurostimulation Devices Market, Spain, Average Price ($), Historic, 2009-2016
Table 38: Neurostimulation Devices Market, Spain, Average Price ($), Forecast, 2016-2023
Table 39: Neurostimulation Devices Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 40: Neurostimulation Devices Market, Spain, Company Share by Revenue ($m), USD Constant, 2016
Table 41: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 42: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 43: Neurostimulation Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 44: Neurostimulation Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 45: Neurostimulation Devices Market, United Kingdom, Average Price ($), Historic, 2009-2016
Table 46: Neurostimulation Devices Market, United Kingdom, Average Price ($), Forecast, 2016-2023
Table 47: Neurostimulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 48: Neurostimulation Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016
Table 49: Neurostimulation Devices Market Pipeline Products

List of Figures
Figure 1: Neurostimulation Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2009-2023
Figure 2: Neurostimulation Devices Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2009-2023
Figure 3: Neurostimulation Devices Market, EU5, Revenue ($m), Historic, USD Constant, 2009-2016
Figure 4: Neurostimulation Devices Market, EU5, Revenue ($m), Forecast, USD Constant, 2016-2023
Figure 5: Neurostimulation Devices Market, EU5, Volume (Units), 2009-2023
Figure 6: Neurostimulation Devices Market, EU5, Volume (Units), Historic, 2009-2016
Figure 7: Neurostimulation Devices Market, EU5, Volume (Units), Forecast, 2016-2023
Figure 8: Neurostimulation Devices Market, EU5, Company Share (%) 2016
Figure 9: Neurostimulation Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 10: Neurostimulation Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 11: Neurostimulation Devices Market, France, Volume (Units), Historic, 2009-2016
Figure 12: Neurostimulation Devices Market, France, Volume (Units), Forecast, 2016-2023
Figure 13: Neurostimulation Devices Market, France, Company Share (%) 2016
Figure 14: Neurostimulation Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 15: Neurostimulation Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 16: Neurostimulation Devices Market, Germany, Volume (Units), Historic, 2009-2016
Figure 17: Neurostimulation Devices Market, Germany, Volume (Units), Forecast, 2016-2023
Figure 18: Neurostimulation Devices Market, Germany, Company Share (%) 2016
Figure 19: Neurostimulation Devices Market, Italy, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 20: Neurostimulation Devices Market, Italy, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 21: Neurostimulation Devices Market, Italy, Volume (Units), Historic, 2009-2016
Figure 22: Neurostimulation Devices Market, Italy, Volume (Units), Forecast, 2016-2023
Figure 23: Neurostimulation Devices Market, Italy, Company Share (%) 2016
Figure 24: Neurostimulation Devices Market, Spain, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 25: Neurostimulation Devices Market, Spain, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 26: Neurostimulation Devices Market, Spain, Volume (Units), Historic, 2009-2016
Figure 27: Neurostimulation Devices Market, Spain, Volume (Units), Forecast, 2016-2023
Figure 28: Neurostimulation Devices Market, Spain, Company Share (%) 2016
Figure 29: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 30: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 31: Neurostimulation Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 32: Neurostimulation Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 33: Neurostimulation Devices Market, United Kingdom, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Medtronic Plc
  • St. Jude Medical LLC
  • Boston Scientific Corp
  • LivaNova PLC
  • Integra LifeSciences Holdings Corp
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll